United Immunity Co., Ltd., an innovative biotech company
developing a Myeloid Targeting Platform™, announced today that Prof. Yvette van Kooyk has joined the company’s scientific advisory board (SAB).
See further information on the press release.
(20240902 – UI Press Release_Prof van Kooyk joins UI Scientific Advisory Board)